Cleared Traditional

K992829 - CASCADE LIQUID COAGULATION CONTROL LEVELS 1, 2, AND 3

K992829 is an FDA 510(k) clearance for CASCADE LIQUID COAGULATION CONTROL LEVELS 1, manufactured by Medical Analysis Systems, Inc.. The device is a Class 2 Hematology device with product code GGN cleared through the Traditional 510(k) pathway after a 91-day FDA review.

K992829 · Medical Analysis Systems, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1999
Decision
91d
Days
Class 2
Risk

K992829 is an FDA 510(k) clearance for the CASCADE LIQUID COAGULATION CONTROL LEVELS 1, 2, AND 3. Classified as Plasma, Coagulation Control (product code GGN), Class II - Special Controls.

Submitted by Medical Analysis Systems, Inc. (Camarillo, US). The FDA issued a Cleared decision on November 22, 1999 after a review of 91 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5425 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Medical Analysis Systems, Inc. devices

FDA 510(k) Submission Details - K992829

510(k) Number K992829 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 23, 1999
Decision Date November 22, 1999
Days to Decision 91 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d faster than avg
Panel avg: 113d · This submission: 91d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GGN Device Classification - Class 2, Special Controls

Product Code GGN Plasma, Coagulation Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GGN Plasma, Coagulation Control

All 91
Devices cleared under the same product code (GGN) and FDA review panel - the closest regulatory comparables to K992829.
THROMBOSTRATE CONTROL PLASMAS
K000679 · Pacific Hemostasis · Mar 2000
HMP CONTROLS (TAS) RAPIDPOINT
K994159 · Cardiovascular Diagnostics, Inc. · Feb 2000
POLLER CALIBRANTS
K991439 · European Concerted Action on Anticoagulation · Dec 1999
HEPARIN CONTROL PLASMA LEVEL 1
K992278 · Pacific Hemostasis · Aug 1999
HEPARIN CONTROL PLASMA LEVEL 2
K992279 · Pacific Hemostasis · Aug 1999
LYPOCHEK COAGULATION CONTROL, MODEL NOS. 787, 788, 789
K990858 · Bio-Rad · Apr 1999